Commission Actions

Show: 20 | 50 | 100
Displaying 20 results
Displaying 141 - 160 of 32854

Pages

September 11, 2020

Press Release: FTC Approves Final Order Requiring Animal Health Product Suppliers Elanco Animal Health, Inc. and Bayer Animal Health GmbH to Divest Assets in Three Product Markets as a Condition of Acquisition
Case: Axon Enterprise and Safariland, In the Matter of
Matter Number: 1810162
Case: Elanco Animal Health and Bayer
Matter Number: 191 0198

September 10, 2020

Press Release: FTC Releases Agenda for September Workshop on Data Portability
Public Event: Cmr. Chopra meets with the Coin Laundry Association

September 9, 2020

Press Release: Operators of Student Debt Relief Scheme Agree to Pay at Least $835,000 to Settle FTC Allegations
Case: Arete Financial Group
Matter Number: 192 3040

September 8, 2020

Press Release: FTC Refunds Almost $3.9 Million to Purchasers of Deceptively Advertised Quell Wearable Pain-Relief Device
Public Event: Cmr. Phillips fireside chat at the Antitrust in the Financial Sector, 4th Annual Conference
Case: Age of Learning, Inc. (ABCmouse)
Matter Number: 172 3186
Case: Neurometrix, Inc.
Matter Number: 172 3130

September 4, 2020

Press Release: FTC to Hold Virtual Workshop November 10 on Franchise Rule
Press Release: FTC Approves Final Order Imposing Conditions on AbbVie Inc.’s Acquisition of Allergan plc
Press Release: Federal Trade Commission and U.S. Department of Justice Antitrust Division to Co-Host the 19th Annual International Competition Network Conference
Press Release: Auto Dealer Group to Cease Business Operations As Part of FTC Settlement
Federal Register Notice: 16 CFR Part 436: Franchise Rule: Announcement of an Online Public Workshop on November 10, 2020 and of the Opportunity to File Comments and Requests to Participate
Matter Number: R511003
Case: National Urological Group, Inc., et al.
Matter Number: 022 3165
Case: Traffic Jam Events, LLC, In the Matter of
Matter Number: X200041
Case: Axon Enterprise and Safariland, In the Matter of
Matter Number: 1810162
Case: AbbVie Inc. and Allergan plc, In the Matter of
Matter Number: 191 0169

Pages